Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.

Witt KL, Shelby MD, Itchon-Ramos N, Faircloth M, Kissling GE, Chrisman AK, Ravi H, Murli H, Mattison DR, Kollins SH.

J Am Acad Child Adolesc Psychiatry. 2008 Dec;47(12):1375-83. doi: 10.1097/CHI.0b013e3181893620.

2.

Cytogenetic effects in children treated with methylphenidate.

El-Zein RA, Abdel-Rahman SZ, Hay MJ, Lopez MS, Bondy ML, Morris DL, Legator MS.

Cancer Lett. 2005 Dec 18;230(2):284-91.

PMID:
16297714
3.

Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.

Ponsa I, Ramos-Quiroga JA, Ribasés M, Bosch R, Bielsa A, Ordeig MT, Morell M, Miró R, de Cid R, Estivill X, Casas M, Bayés M, Cormand B, Hervás A.

Mutat Res. 2009 Jun 18;666(1-2):44-9. doi: 10.1016/j.mrfmmm.2009.03.014.

PMID:
19457516
4.

Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder.

Tucker JD, Suter W, Petibone DM, Thomas RA, Bailey NL, Zhou Y, Zhao Y, Muniz R, Kumar V.

Mutat Res. 2009 Jun-Jul;677(1-2):53-8. doi: 10.1016/j.mrgentox.2009.05.005.

PMID:
19465145
5.

No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.

Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.

Toxicol Lett. 2009 Jan 10;184(1):38-43. doi: 10.1016/j.toxlet.2008.10.011.

PMID:
19015014
6.

Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.

Preston RJ, Kollins SH, Swanson JM, Greenhill LL, Wigal T, Elliott GR, Vitiello B.

Cancer Lett. 2005 Dec 18;230(2):292-4. No abstract available.

PMID:
16019134
7.

Methylphenidate and chromosome damage.

Jacobson-Kram D, Mattison D, Shelby M, Slikker W, Tice R, Witt K.

Cancer Lett. 2008 Feb 18;260(1-2):216-8. No abstract available.

PMID:
18055105
8.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
9.

Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.

Stein MA, Waldman ID, Charney E, Aryal S, Sable C, Gruber R, Newcorn JH.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):581-8. doi: 10.1089/cap.2011.0018.

10.

Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.

Winterstein AG, Gerhard T, Shuster J, Saidi A.

Pediatrics. 2009 Jul;124(1):e75-80. doi: 10.1542/peds.2008-3138.

11.

Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.

Pliszka SR, Matthews TL, Braslow KJ, Watson MA.

J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):520-6.

PMID:
16670648
12.

[The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].

Frölich J, Banaschewski T, Spanagel R, Döpfner M, Lehmkuhl G.

Z Kinder Jugendpsychiatr Psychother. 2012 Sep;40(5):287-99; quiz 299-300. doi: 10.1024/1422-4917/a000185. German.

PMID:
22869222
14.

Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?

Walitza S, Werner B, Romanos M, Warnke A, Gerlach M, Stopper H.

Environ Health Perspect. 2007 Jun;115(6):936-40.

15.

An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.

Shang CY, Pan YL, Lin HY, Huang LW, Gau SS.

J Child Adolesc Psychopharmacol. 2015 Sep;25(7):566-73. doi: 10.1089/cap.2015.0035.

PMID:
26222447
16.

24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.

Stowe CD, Gardner SF, Gist CC, Schulz EG, Wells TG.

Ann Pharmacother. 2002 Jul-Aug;36(7-8):1142-9.

PMID:
12086544
17.

Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children.

Walitza S, Kämpf K, Oli RG, Warnke A, Gerlach M, Stopper H.

Toxicol Lett. 2010 Mar 1;193(1):4-8. doi: 10.1016/j.toxlet.2009.12.013. Review.

PMID:
20026394
18.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
19.

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.

20.
Items per page

Supplemental Content

Support Center